Author(s): Smita S. Aher, Saroj P. Gajare, Ravindra B. Saudagar

Email(s): sarojgajare19@gmail.com

DOI: 10.5958/0974-360X.2017.00573.X   

Address: Smita S. Aher1, Saroj P. Gajare2, Ravindra B. Saudagar1
1Department of Pharmaceutical Chemistry, R. G. Sapkal College of Pharmacy, Anjaneri, Nasik.
2Department of Quality Assurance Techniques, R. G. Sapkal College of Pharmacy, Anjaneri, Nasik.
*Corresponding Author

Published In:   Volume - 10,      Issue - 9,     Year - 2017


ABSTRACT:
Diabetes mellitus is a chronic condition prevalent worldwide. It is estimated that more than 246 million individuals have diabetes, with this number expected to increase to 366 million by the year 2030. The chronic hyperglycemia of diabetes is associated with long term damage to various organs, including the eyes, kidneys, nervous system, heart, and vasculature. India has a long history regarding the epidemiology of diabetes. In an effort to optimize glycemic control and also to reduce the burden of diabetic complications, several classes of oral hypoglycemic agents have been developed. Linagliptin has now been on the market and has been established as the first-line agent of choice for the management of type 2 diabetes. In this way, linagliptin is anticipated to reduce insulin resistance, contribute to weight loss, and play a significant role in the improvement of cardiovascular outcomes.


Cite this article:
Smita S. Aher, Saroj P. Gajare, Ravindra B. Saudagar. Linagliptin: A Review on Therapeutic Role in Diabetes Mellitus. Research J. Pharm. and Tech. 2017; 10(9): 3233-3236. doi: 10.5958/0974-360X.2017.00573.X


Recomonded Articles:

Author(s): P.Maheshwari, D.Pavithra, Neethu.T.T, T.S. Shanmugarajan, P. Shanmugasundaram

DOI: 10.5958/0974-360X.2017.00011.7         Access: Open Access Read More

Author(s): S. Subasree, Karthikeyan Murthykumar, Dhanraj

DOI: 10.5958/0974-360X.2016.00116.5         Access: Open Access Read More

Author(s): Santhosh Kumar V, Praveen D

DOI: 10.5958/0974-360X.2016.00123.2         Access: Open Access Read More

Author(s): Leelavathi D Acharya, N R Rau, N Udupa, Surulivel Rajan M, Vijayanarayana K

DOI: 10.5958/0974-360X.2016.00162.1         Access: Open Access Read More

Author(s): S.M. Charjan, S.K. Bais, R.R. Shiradkar, R.L. Bakal, V.M. Durge, A.V. Chandewar

DOI: Not Available         Access: Open Access Read More

Author(s): Vaddi Mounika, S. Sarumathy, J. Anisha Ebens, T. S. Shanmugarajan

DOI: 10.5958/0974-360X.2017.00003.8         Access: Open Access Read More

Author(s): Vaseeha Banu T.S., Sandhya K.V., K.N. Jayaveera

DOI: Not Available         Access: Open Access Read More

Author(s): Swathy. S, Gheena. S, Sri Varsha. L

DOI: 10.5958/0974-360X.2015.00291.7         Access: Open Access Read More

Author(s): Surendra Nath Pandeya, Rajeev Kumar, Arun Kumar, Ashish Kumar Pathak

DOI: Not Available         Access: Open Access Read More

Author(s): Shikha Batra, Nikhil Batra, Anil Pareek, Badri Prakash Nagori

DOI: Not Available         Access: Open Access Read More

Author(s): Kalaivanan S, Sarumathy S, Anisha Ebens J, Naresh Kumar K, Roobena Parveen A, Nasreen Ashraf M.

DOI: 10.5958/0974-360X.2017.00005.1         Access: Open Access Read More

Author(s): Ranadheer Chowdary P, Praveen. D, Vijey Aanandhi. M

DOI: 10.5958/0974-360X.2017.00086.5         Access: Open Access Read More

Research Journal of Pharmacy and Technology (RJPT) is an international, peer-reviewed, multidisciplinary journal.... Read more >>>

RNI: CHHENG00387/33/1/2008-TC                     
DOI: 10.5958/0974-360X 

0.38
2018CiteScore
 
56th percentile
Powered by  Scopus


SCImago Journal & Country Rank


Recent Articles




Tags